Skip to main content

Copaxone

Pronunciation: co-PAX-own
Generic name: glatiramer acetate
Dosage form: injection for subcutaneous use
Drug class: Other immunostimulants

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 9, 2024.

What is Copaxone?

Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease).

Copaxone's mechanism of action is not fully understood but may involve modification of the immune system processes that cause MS. Copaxone acts locally rather than causing broad immune suppression and contains glatiramer acetate, a combination of the acetate salts of four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine. These amino acids resemble the myelin protein surrounding nerve fibers. They are thought to act as a decoy to divert an immune attack away from your myelin (see How does Copaxone work for multiple sclerosis?). Copaxone will not cure MS, but it can make relapses occur less often.

Copaxone injection belongs to the drug class called immunomodulatory agents. It may also be called an immunostimulant.

Copaxone gained FDA approval on December 20, 1996. A Copaxone generic is available under the name glatiramer acetate.

Copaxone Co-Pay assistance

Commercially insured patients taking Copaxone may pay as little as $0 with Copaxone Co-Pay Solutions. More than 70% of Copaxone patients pay less than $10 per month out of pocket. Enrolment is through MySharedSolutions.com

The card is not valid for Medicare, Medicaid, Medigap, VA, DOD, TRICARE, and some other insurance plans.

See Copaxone Prices, Coupons, Copay Cards & Patient Assistance for more information.

Copaxone side effects

The most common side effects of Copaxone are:

Serious side effects and warnings

Copaxone may cause the following serious side effects.

Immediate Copaxone injection reactions. Serious side effects may happen right after or within minutes after you inject Copaxone injection at any time during your course of treatment. Call your healthcare provider right away if you have any of these immediate post-injection reaction symptoms including:

If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a healthcare provider tells you to.

Chest Pain. You can have chest pain as part of an immediate Copaxone injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using Copaxone. Call your healthcare provider right away if you have chest pain while using Copaxone injection.

Damage to your skin. Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use Copaxone. Damage to the fatty tissue under your 
skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by:

Liver problems. Liver problems, including liver failure, can occur with Copaxone. Call your healthcare provider right away if you have symptoms, such as:

Allergic reactions. Get emergency medical help if you have signs of an allergic reaction to Copaxone: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

It is not known if Copaxone is safe and effective in children aged less than 18 years. Copaxone is not approved for use by anyone younger than 18 years old.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Copaxone. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before using

Do not use Copaxone if you are allergic to glatiramer, Copaxone, or any of the inactive ingredients in the injection, including mannitol.

Tell your healthcare provider about all of your medical conditions, including if you:

Pregnancy

It is not known if Copaxone will harm your unborn baby.

Breastfeeding

Clinically relevant levels of Copaxone are not expected to pass into breast milk, but it is not known if Copaxone affects breast milk production. Talk to your healthcare provider about the best way to feed your baby while using Copaxone.

How should I use Copaxone?

Use Copaxone injection exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Read and carefully follow any Instructions for Use provided with your medicine. Do not use Copaxone if you don't understand all instructions for proper use. Ask your doctor or pharmacist if you have questions.

Copaxone is injected under the skin (this is called subcutaneously).

Copaxone injections are given either daily or 3 times per week, depending on your dose.

Some glatiramer acetate products can be used with an optional compatible autoinjector. Compatible autoinjectors are supplied separately if available, but the availability of compatible autoinjectors may change with time.

Some people receiving a Copaxone injection have had a severe reaction. Tell your caregiver right away if you feel anxious, warm, itchy, tingly, or have a pounding heartbeat, tightness in your throat, or trouble breathing during the injection. This type of reaction may occur even after you have been using this medicine for several months.

Call your doctor at once if you have:

Dosing information

Usual Adult Dose of Copaxone for Multiple Sclerosis: Copaxone 20 mg subcutaneously once a day or Copaxone 40 mg subcutaneously 3 times a week.

Although Copaxone starts working after your first injection, it may take 6 to 9 months to become fully effective and is considered a long-term treatment for MS (see How long can you take Copaxone?). In older patients, discontinuing Copaxone does not appear to make any difference to MS relapse rates (see What happens if an MS patient stops taking Copaxone?).

What happens if I miss a dose?

Use the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Copaxone?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What other drugs will affect Copaxone?

Other drugs may interact with glatiramer, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Does Copaxone interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Copaxone storage

Store Copaxone prefilled syringes in the refrigerator. Do not freeze. Throw away any syringe that has been frozen.

If refrigeration is not available, a Copaxone prefilled syringe will keep for up to 30 days if stored at room temperature. Protect from moisture, light, and high heat.

Copaxone ingredients

Active ingredient: glatiramer acetate
Inactive ingredients: mannitol.

Available as:

• Copaxone 20 mg/mL in a single-dose prefilled syringe with a white plunger.
• Copaxone 40 mg/mL in a single-dose, prefilled syringe with a blue plunger.

Who makes Copaxone?

Teva Neuroscience, Inc., manufactures Copaxone injection.

Popular FAQ

Where and how should Copaxone be injected?

Copaxone should be by subcutaneous injection (into the fatty layer under the skin) into the upper outer arms, abdomen (but not within two inches of your belly button), fleshy part of the hips, or top outer part of the thighs. There are two recognized strengths of Copaxone, 20mg/ml and 40mg/ml. Copaxone 20mg/mL should be administered once daily, every day and Copaxone 40mg/ml should be administered three times per week (at least 48 hours between dosages), and preferably on the same day each week, for example, Monday, Wednesday, and Friday. Continue reading

More FAQ

View more FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.